HRTS Company Profile and Key Details

Tema Heart & Health ETF (NASDAQ:HRTS) closed at $36.03 USD, losing -$0.14 (-0.39%) from the previous close of $36.17. The stock is currently mid-range between its 52-week high and low $29.54 and $38.87. With a market capitalization of about $53.45 million, Tema Heart & Health ETF is classified as a micro-cap and shows lower-than-market volatility (beta ~0.65). Key stats such as the average daily volume over the past year has been around 5.08 thousand shares, volume is running light vs its 52-week average. Headquartered in New York, NY, Tema Heart & Health ETF operates in the Financial Services sector and the Asset Management industry. The Tema Heart & Health ETF (HRTS) is designed to strategically invest in companies poised to benefit from cutting-edge developments within the biotechnology and broader healthcare industries.

Short-term trend indicators are mixed aligned (SMA20 -0.26%, SMA50 -0.31%, SMA200 12.04%). The stock’s 14-day RSI is 47.26 (neutral), while the ATR of 0.34 points to tighter daily ranges. The stock remains hovering near 52-week lows, trading -2.89% below its high and over 40.57% above its low. Average 10-day trading volume of 2.33 thousand shares is below the 3-month average of 5.08 thousand, indicating normal recent market interest.

Tema Heart & Health ETF last paid a dividend of 0.47 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.00.

Our AI price prediction model suggests that Tema Heart & Health ETF stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term.

currently trading near 52-week highs band.